Literature DB >> 20383980

Optimisation of the frequently sampled intravenous glucose tolerance test to reduce urinary glucose spilling in horses.

F Tóth1, N Frank, S B Elliott, K Perdue, R J Geor, R C Boston.   

Abstract

REASONS FOR PERFORMING STUDY: The frequently sampled i.v. glucose tolerance test (FSIGTT) is used to evaluate glucose and insulin dynamics in horses, but it has not been determined whether urinary glucose spilling (UGS) affects results. HYPOTHESIS: UGS occurs in horses during the FSIGTT and this problem can be minimised by adjusting the dextrose and insulin dosages used.
METHODS: Six mature mares were included in this study. In the first phase, 6 FSIGTT procedures were performed in each horse to evaluate 6 different dextrose dosages. Six different insulin dosages were evaluated during the second phase of the study after administration of 300 mg/kg bwt dextrose. Area under the glucose (AUCg) and insulin (AUCi) curves were calculated and minimal model analyses performed. UGS was measured in the third and fourth phases of the study during the combined glucose insulin test and established FSIGTT. A new FSIGTT was developed and evaluated.
RESULTS: Positive linear effects of dextrose dosage on AUCg, AUCi and acute insulin response to glucose were detected, with AUCg reaching a plateau at doses > or =200 mg/kg bwt. Insulin dosage had an inverse linear effect on AUCg, but other values remained unaffected. UGS occurred during all 3 tests and was the highest for the established FSIGTT and the lowest for the new FSIGTT. The type of FSIGTT performed did not affect minimal model results.
CONCLUSIONS: Results indicate that the dextrose dosage of 300 mg/kg bwt used in the established FSIGTT is too high. UGS can be reduced by lowering the dextrose dosage to 100 mg/kg bwt. POTENTIAL RELEVANCE: A new FSIGTT involving the administration of 100 mg/kg bwt dextrose followed by 20 mu/kg bwt insulin 20 min later is recommended for use in horses because this test provides adequate data for minimal model analysis while minimising UGS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20383980     DOI: 10.2746/042516409x439661

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  6 in total

1.  Chromium propionate increases insulin sensitivity in horses following oral and intravenous carbohydrate administration.

Authors:  Jerry W Spears; Karen E Lloyd; Paul Siciliano; Shannon Pratt-Phillips; Ellen W Goertzen; Sarah J McLeod; Jennifer Moore; Kristi Krafka; Jill Hyda; Whitney Rounds
Journal:  J Anim Sci       Date:  2020-04-01       Impact factor: 3.159

2.  The Effect of Fasting Duration on Baseline Blood Glucose Concentration, Blood Insulin Concentration, Glucose/Insulin Ratio, Oral Sugar Test, and Insulin Response Test Results in Horses.

Authors:  F R Bertin; S D Taylor; A W Bianco; J E Sojka-Kritchevsky
Journal:  J Vet Intern Med       Date:  2016-08-02       Impact factor: 3.333

3.  Evaluation of Four Diagnostic Tests for Insulin Dysregulation in Adult Light-Breed Horses.

Authors:  L K Dunbar; K A Mielnicki; K A Dembek; R E Toribio; T A Burns
Journal:  J Vet Intern Med       Date:  2016-03-25       Impact factor: 3.333

4.  Blood glucose and insulin concentrations after alpha-2-agonists administration in horses with and without insulin dysregulation.

Authors:  Janice E Kritchevsky; Genevieve S Muir; Dakota H Z Leschke; Jack K Hodgson; Emily K Hess; Francois-Rene Bertin
Journal:  J Vet Intern Med       Date:  2020-02-26       Impact factor: 3.333

5.  Comparison of insulin sensitivity between healthy neonatal foals and horses using minimal model analysis.

Authors:  Hannah M Kinsella; Laura D Hostnik; Hailey A Snyder; Sarah E Mazur; Ahmed M Kamr; Teresa A Burns; John C Mossbarger; Ramiro E Toribio
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

6.  Investigating the Relationship Between Cardiac Function and Insulin Sensitivity in Horses: A Pilot Study.

Authors:  Natasha J Williams; Martin Furr; Cristobal Navas de Solis; Allison Campolo; Michael Davis; Véronique A Lacombe
Journal:  Front Vet Sci       Date:  2022-07-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.